Clinical Trial Update: A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating apremilast for safety and efficacy in Japanese children with moderate to severe plaque psoriasis; status indicates active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Amgen | Conditions: Plaque Psoriasis | Phase 3 | Status: ACTIVE_NOT_RECRUITING